Terri Sharp in Bardstown, Kentucky

Home Kentucky Bardstown

Terri Sharp has Nurse Practitioner as her primary medical specialty. Their primary office is: 331 S 3rd St in Bardstown, Kentucky. There is an additional office location, for a total of two, for Terri Sharp that can be viewed further down.

They're a part of the: Communicare Inc medical group which has around 19 members. You can call their office at 502-348-9206 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2007 (around 17 years of experience). They are listed as doing telehealth appointments.

Terri J. Sharp Office Phone and Directions

Terri Sharp
Communicare Inc
331 S 3rd St
Bardstown, Kentucky 40004
502-348-9206

Patient Ratings
Please rate your experience with Terri Sharp below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 502-348-9206

Enter a starting address:

Healthcare Info for Terri Sharp

Medical School: Sorry, her university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Terri Sharp is listed as: Nurse Practitioner
Approximate Years of Experience: 17
PAC (PECOS ID)#: 2062700461
NPI #: 1801081203
NPI Created On: 09/09/2007
NPI Last Updated Listed as: 04/19/2019
Primary Taxonomy Code: 363LF0000X
License Number:
5256P
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Psychotherapy, 30 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 25 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $13

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 845187053

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: PSYCHOLOGY

Name of Drug #1: QELBREE

Open Associated Drug #1: 17772-133-01